0001209191-23-058458.txt : 20231213
0001209191-23-058458.hdr.sgml : 20231213
20231213134019
ACCESSION NUMBER: 0001209191-23-058458
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231212
FILED AS OF DATE: 20231213
DATE AS OF CHANGE: 20231213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Quinn William P.
CENTRAL INDEX KEY: 0001724190
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39988
FILM NUMBER: 231483587
MAIL ADDRESS:
STREET 1: SUNESIS PHARMACEUTICALS, INC.
STREET 2: 395 OYSTER POINT BOULEVARD, SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bolt Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001641281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472804636
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-665-9295
MAIL ADDRESS:
STREET 1: 900 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER COMPANY:
FORMER CONFORMED NAME: Bolt Therapeutics, Inc.
DATE OF NAME CHANGE: 20150504
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-12
0
0001641281
Bolt Biotherapeutics, Inc.
BOLT
0001724190
Quinn William P.
C/O BOLT BIOTHERAPEUTICS, INC.
900 CHESAPEAKE DRIVE
REDWOOD CITY
CA
94063
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-06-06
4
P
0
1829
1.1815
A
26272
D
Common Stock
2023-12-06
4
P
0
2500
0.782
A
28772
D
Common Stock
2023-12-12
4
P
0
7500
0.95
A
36272
D
Shares acquired under the issuer's Employee Stock Purchase Plan.
/s/ William P. Quinn
2023-12-13